Collegium Pharmaceutical, Inc. (COLL)

NASDAQ: COLL · Real-Time Price · USD

25.32

+0.37 (1.48%)

Nov 13, 2026, 4:00 PM EST - Market closed

Collegium Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	787	1,464	924	1,004	779	650
Market Cap Growth	-47.43%	58.40%	-7.95%	28.87%	19.82%	-6.16%
Enterprise Value	1,850	2,114	1,797	1,418	1,377	727
Last Close Price	25.32	46.30	28.65	30.78	23.20	18.68

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	22.36	23.28	13.35	20.84	-	9.09
Forward PE	3.63	6.11	4.54	5.57	4.01	4.57
PS Ratio	0.97	1.88	1.46	1.77	1.68	2.35
PB Ratio	2.65	4.85	4.04	5.14	4.00	3.20
P/FCF Ratio	2.34	4.47	4.54	3.66	6.35	6.40
P/OCF Ratio	2.33	4.44	4.51	3.65	6.27	6.28
PEG Ratio	0.73	0.16	0.16	0.16	0.17	1.08

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.27	2.71	2.85	2.50	2.97	2.63
EV/EBITDA Ratio	4.41	5.04	4.87	4.37	7.99	7.98
EV/EBIT Ratio	9.91	10.95	9.00	8.08	36.13	32.76
EV/FCF Ratio	5.50	6.45	8.84	5.17	11.23	7.16

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	4.07	3.10	4.28	3.45	3.64	1.27
Debt / EBITDA Ratio	2.83	2.20	2.63	2.06	4.04	2.75
Debt / FCF Ratio	3.59	2.86	4.82	2.46	5.78	2.55
Net Debt / Equity Ratio	3.59	1.82	3.57	1.86	2.75	0.36
Net Debt / EBITDA Ratio	2.53	1.31	2.22	1.12	3.11	0.79
Net Debt / FCF Ratio	3.16	1.68	4.02	1.33	4.37	0.71
Asset Turnover	0.44	0.47	0.45	0.49	0.50	0.41
Inventory Turnover	1.37	2.27	2.46	2.41	3.70	3.58
Quick Ratio	0.76	1.36	0.77	1.07	0.82	1.05
Current Ratio	1.01	1.57	0.95	1.17	0.97	1.13
Return on Equity (ROE)	13.36%	23.70%	32.62%	24.68%	-12.57%	36.77%
Return on Assets (ROA)	6.30%	7.27%	8.89%	9.46%	2.55%	2.08%
Return on Invested Capital (ROIC)	12.25%	13.82%	17.46%	17.30%	7.58%	8.02%
Return on Capital Employed (ROCE)	12.50%	15.90%	17.30%	25.60%	5.10%	5.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	4.47%	4.30%	7.49%	4.80%	-3.21%	11.00%
FCF Yield	42.74%	22.38%	22.01%	27.33%	15.74%	15.63%
Buyback Yield / Dilution	11.72%	1.79%	3.26%	-23.53%	17.58%	-16.77%

SEC Filings: 10-K · 10-Q